Buscar resultados de ensayos clínicos
Corneal Neovascularization - 20 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Bevacizumab for the Treatment of Corneal Neovascularization Condición: Corneal Neovascularization Fecha: 2009-10-08 Intervenciones: Drug: Bevacizumab Topical 10 mg/cc or subconjunctival 2.5 mg/0.1cc |
Completed |
Nombre del estudio: Treatment of Corneal Neovascularization With Topical Pazopanib Condición: Corneal Neovascularization Fecha: 2010-11-22 Intervenciones: Drug: Pazopanib (5mg/ml) Topical pazopanib, 4 times per day for 3 weeks |
Completed |
Nombre del estudio: Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization Condición: Corneal Neovascularization Fecha: 2007-11-07 Intervenciones: Drug: Bevacizumab (Avastin) One dose of 0.1cc of subconjunctival Bevacizumab was applied |
Completed |
Nombre del estudio: The Effect of Bevacizumab on Corneal Neovascularization Condición: Corneal Neovascularization Fecha: 2008-11-22 Intervenciones: Drug: Bevacizumab subconjunctival injection of 1.25 mg bevacizumab and had a follow-up of at least 2 mon |
Not yet recruiting |
Nombre del estudio: Strategies for Management of Corneal Neovascularisation Condición: Corneal Neovascularisation Fecha: 2015-10-27 Intervenciones:
|
Terminated |
Nombre del estudio: Topical IL-1-Ra for Treatment of Corneal Neovascularization Condición: Corneal Neovascularization Fecha: 2009-06-04 Intervenciones:
|
Completed |
Nombre del estudio: Topical Avastin for Treatment of Corneal Neovascularization Condición: Corneal Neovascularization Fecha: 2007-11-14 Intervenciones: Drug: Topical Avastin 1% Avastin (bevacizumab) 1% Ot |
Completed |
Nombre del estudio: Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV) Condición: Corneal Neovascularization Fecha: 2008-05-19 Intervenciones: Drug: Ranibizumab 10 Patients will receive treatment (Ranibizumab) |
Completed |
Nombre del estudio: Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization Condición: Corneal Neovascularization Fecha: 2007-08-06 Intervenciones: Drug: Bevacizumab (Avastin) Bevacizumab 10mg/mL 1 drop BID x 3 weeks |
Completed |
Nombre del estudio: Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization Condición: Corneal Neovascularization Fecha: 1999-10-18 Intervenciones:
|